[Maintenance chemotherapy: futility or utility?]. / Chimiothérapie de maintenance: futile ou utile?
Rev Med Suisse
; 11(475): 1103-4, 1106-7, 2015 May 20.
Article
en Fr
| MEDLINE
| ID: mdl-26152084
ABSTRACT
In incurable diseases, maintenance therapy aims to prolong the response achieved through induction. The goal is to delay disease progression, thus prolonging survival. Two maintenance modalities are used. The first, called continuation maintenance, consists of continuing the same agent used in the initial treatment. The second, called switch-maintenance, introduces an early second line drug immediately after induction. Proving the superiority of a maintenance strategy implies a better outcome with the maintenance compared to the same therapeutic agent used upon disease progression. This benefit may be observed in terms of overall survival and/or quality of life.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Inutilidad Médica
/
Quimioterapia de Mantención
/
Neoplasias
Aspecto:
Patient_preference
Límite:
Aged
/
Humans
/
Male
Idioma:
Fr
Revista:
Rev Med Suisse
Asunto de la revista:
MEDICINA
Año:
2015
Tipo del documento:
Article